
Investors Target GeneDx Holdings in Securities Class Action
A federal class action lawsuit now challenges GeneDx Holdings Corp. for alleged violations of the Securities Exchange Act, following a period where the company reportedly misled shareholders regarding its financial health. Investors who purchased WGS stock between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to participate.












.jpg)









